You are here

Novartis

ICER says gene therapy may be more cost effective for spinal muscular atrophy

Yahoo/Reuters

Thu, 12/20/18 - 11:54 pm

spinal muscular atrophy

Novartis seeks to acquire French CAR-T contract manufacturer

Biopharma Dive

Thu, 12/20/18 - 11:43 pm

Novartis unit Alcon picks up Tear Film Innovations

Mass Device

Thu, 12/20/18 - 11:48 am

Tear Film Innovations

Novartis oncology CEO quits after less than a year

Pharmaforum

Thu, 12/20/18 - 10:07 am

Susanne Schaffert

Alcon's Acquisition Is a Real Tear-Jerker

Medical Devices and Diagnostics Industry

Thu, 12/20/18 - 12:22 am

As promised, Novartis eyes new method for funding ultrapricey next-gen drugs: FT

Fierce Pharma

Wed, 12/19/18 - 12:37 am

Novartis unit teams up with medical marijuana producer, marking milestone for pharma

Stat

Tue, 12/18/18 - 12:53 pm

Medical Marijuana

Novartis, still struggling with Kymriah manufacturing, is providing some out-of-spec doses to patients who ask

Fierce Pharma

Tue, 12/18/18 - 12:51 pm

drug manufacturing

2 Sets of Disasters Biotech Will Pay For in 2019

Yahoo/Motley Fool

Mon, 12/17/18 - 12:16 am

Gilead Sciences

Spark Therapeutics

Novartis gets EC approval for self-administration of Xolair across all indications

Pharmaceutical Business Review

Fri, 12/14/18 - 02:30 pm

severe allergic asthma

chronic spontaneous urticaria

Novartis CEO calls for cultural shift to cater for millennial generation

Pharmafile

Sat, 12/8/18 - 12:22 pm

Novartis sheds light on liquid biopsies with SOLAR-1 analysis

Biopharma Dive

Fri, 12/7/18 - 12:03 pm

Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount

Fierce Pharma

Thu, 12/6/18 - 01:37 pm

Teva Pharmaceutical

Novartis, aiming to protect blockbuster sales, advances Xolair follow-up to phase 3

Fierce Pharma

Thu, 12/6/18 - 12:55 pm

clinical trials

Novartis’ partners at Conatus have another NASH setback to confess today

Endpoints

Wed, 12/5/18 - 07:43 pm

clinical trials

Novartis plots to retain hives patients with monoclonal antibody that outshines Xolair

Endpoints

Tue, 12/4/18 - 09:43 am

monoclonal antibodies

clinical trials

Novartis’ SMA Gene Therapy Is on the Fast Track for Approval

BioSpace

Mon, 12/3/18 - 05:55 pm

priority review

All in: Novartis adds another drug to its fast-growing radiopharmaceuticals division

Endpoints

Mon, 12/3/18 - 12:10 pm

radiopharmaceuticals

Fujifilm Toyama

Advanced Accelerator Application

ASH: Gilead, Novartis tout long-term data for CAR-T slow starters Yescarta, Kymriah

Fierce Pharma

Sun, 12/2/18 - 11:01 pm

Novartis’ Gilenya gets approval in Europe to treat children and adolescents with MS

Pharmaceutical Business Review

Fri, 11/30/18 - 10:21 am

Relapsing Remitting Multiple Sclerosis

Pages